NCT03742544View on ClinicalTrials.gov

Post Marketing Surveillance of Telostop TAB (Telmisartan/Rosuvastatin) for Evaluating the Safety and Efficacy

UnknownOBSERVATIONAL
Enrollment

600

Participants

Timeline

Start Date

June 23, 2015

Primary Completion Date

October 30, 2020

Study Completion Date

October 30, 2020

Conditions
HypertensionDyslipidemias
Sponsors
All Listed Sponsors
lead

IlDong Pharmaceutical Co Ltd

INDUSTRY

NCT03742544 - Post Marketing Surveillance of Telostop TAB (Telmisartan/Rosuvastatin) for Evaluating the Safety and Efficacy | Biotech Hunter | Biotech Hunter